Albuminuria With Preserved Estimated Glomerular Filtration Rate and Prevalent Cardiovascular Disease Among Adults in the United States: A Cross-Sectional Analysis of the National Health and Nutrition Examination Survey 2021-2023

Background: Albuminuria is a marker of kidney damage and cardiovascular risk, but routine creatinine-based assessment of estimated glomerular filtration rate (eGFR) does not detect it. We estimated how common albuminuria with preserved eGFR is among U.S. adults and examined its association with prevalent cardiovascular disease (CVD). Materials and methods: We analyzed 5,282 nonpregnant adults aged ≥20 years from the National Health and Nutrition Examination Survey, August 2021-August 2023. Participants were classified into four phenotypes by eGFR (2021 race-free CKD-EPI creatinine equation; cut point 60 mL/min/1.73 m²) and spot urine albumin-to-creatinine ratio (UACR; cut point 30 mg/g). Prevalent CVD was a self-reported diagnosis of heart failure, coronary heart disease, angina, myocardial infarction, or stroke. Associations were estimated with survey-weighted logistic regression, and the main estimates were independently reproduced in a second statistical software package. Secondary analyses estimated the share of affected adults with no diagnosed hypertension, diabetes, kidney disease, or CVD and the change in predicted 10-year total CVD risk when UACR was added to the American Heart Association Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) equations. Results: Albuminuria with preserved eGFR was present in 7.8% of U.S. adults (95% confidence interval (CI): 6.9-8.7), or about 17.4 million people, and accounted for 79.1% of all adults with albuminuria. CVD prevalence was 22.2% in this group versus 6.4% in adults without kidney markers (adjusted odds ratio (OR): 1.86; 95% CI: 1.23-2.81). A simplified model with fewer parameters gave a similar result (OR: 1.87; 95% CI: 1.24-2.82). The odds of CVD did not differ significantly from those of adults with reduced eGFR without albuminuria (OR: 1.11; 95% CI: 0.72-1.72) and rose with albuminuria severity (OR: 1.13 per doubling of UACR). Among adults with albuminuria and preserved eGFR, 35.6% reported no diagnosis of hypertension, diabetes, kidney disease, or CVD, and only 3.2% had been told they had kidney disease. Adding UACR to PREVENT raised their mean predicted 10-year total CVD risk from 9.9% to 12.7% and moved 25.2% into a higher risk category. Conclusions: About one in 13 U.S. adults has albuminuria with preserved eGFR. This phenotype was associated with prevalent CVD independently of traditional risk factors, and many affected adults had no diagnosis that would usually prompt urine albumin testing. Prospective studies should test whether wider UACR testing improves cardiovascular prevention.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2026-11-17
DOI
https://doi.org/10.7759/cureus.119834
Primary Topic
Chronic Kidney Disease and Diabetes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Albuminuria With Preserved Estimated Glomerular Filtration Rate and Prevalent Cardiovascular Disease Among Adults in the United States: A Cross-Sectional Analysis of the National Health and Nutrition Examination Survey 2021-2023

Muntaqim Ahmed Raju, Md Ripon Ahammed, Md Shahidullah Kaisar
1 links
Cureus
Chronic Kidney Disease and Diabetes
article

Albuminuria With Preserved Estimated Glomerular Filtration Rate and Prevalent Cardiovascular Disease Among Adults in the United States: A Cross-Sectional Analysis of the National Health and Nutrition Examination Survey 2021-2023

Muntaqim Ahmed Raju, Md Ripon Ahammed, Md Shahidullah Kaisar
article en

Abstract

Background: Albuminuria is a marker of kidney damage and cardiovascular risk, but routine creatinine-based assessment of estimated glomerular filtration rate (eGFR) does not detect it. We estimated how common albuminuria with preserved eGFR is among U.S. adults and examined its association with prevalent cardiovascular disease (CVD). Materials and methods: We analyzed 5,282 nonpregnant adults aged ≥20 years from the National Health and Nutrition Examination Survey, August 2021-August 2023. Participants were classified into four phenotypes by eGFR (2021 race-free CKD-EPI creatinine equation; cut point 60 mL/min/1.73 m²) and spot urine albumin-to-creatinine ratio (UACR; cut point 30 mg/g). Prevalent CVD was a self-reported diagnosis of heart failure, coronary heart disease, angina, myocardial infarction, or stroke. Associations were estimated with survey-weighted logistic regression, and the main estimates were independently reproduced in a second statistical software package. Secondary analyses estimated the share of affected adults with no diagnosed hypertension, diabetes, kidney disease, or CVD and the change in predicted 10-year total CVD risk when UACR was added to the American Heart Association Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) equations. Results: Albuminuria with preserved eGFR was present in 7.8% of U.S. adults (95% confidence interval (CI): 6.9-8.7), or about 17.4 million people, and accounted for 79.1% of all adults with albuminuria. CVD prevalence was 22.2% in this group versus 6.4% in adults without kidney markers (adjusted odds ratio (OR): 1.86; 95% CI: 1.23-2.81). A simplified model with fewer parameters gave a similar result (OR: 1.87; 95% CI: 1.24-2.82). The odds of CVD did not differ significantly from those of adults with reduced eGFR without albuminuria (OR: 1.11; 95% CI: 0.72-1.72) and rose with albuminuria severity (OR: 1.13 per doubling of UACR). Among adults with albuminuria and preserved eGFR, 35.6% reported no diagnosis of hypertension, diabetes, kidney disease, or CVD, and only 3.2% had been told they had kidney disease. Adding UACR to PREVENT raised their mean predicted 10-year total CVD risk from 9.9% to 12.7% and moved 25.2% into a higher risk category. Conclusions: About one in 13 U.S. adults has albuminuria with preserved eGFR. This phenotype was associated with prevalent CVD independently of traditional risk factors, and many affected adults had no diagnosis that would usually prompt urine albumin testing. Prospective studies should test whether wider UACR testing improves cardiovascular prevention.

Cureus
University of Dhaka (BD), Jacobi Medical Center (US)
Good health and well-being
Chronic Kidney Disease and Diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon